Factsheet – How the European Commission works on Rare Diseases and the European Reference Networks (ERNs)

1:1
Overview of the European Commission’s coordinated approach to rare diseases, including policy, research, and the role of European Reference Networks.

This factsheet outlines how the European Commission supports action on rare diseases through policy frameworks, research funding, and collaboration across Member States. It explains the role of European Reference Networks (ERNs) as cross-border networks connecting specialised centres to address rare and complex conditions, and highlights initiatives related to orphan medicines, medical devices, and data sharing, including the European Health Data Space.

Acces this publication
Factsheet – How the European Commission works on Rare Diseases and the European Reference Networks (ERNs)

Year of publication

2026

Source

European Commission – Directorate-General for Health and Food Safety

Author

Directorate-General for Health and Food Safety (European Commission)

You might also be interested in

ERDERA trainings template (9)

The 2027 Open Academy x ERDERA Schools is now open for application

Applications for the 2027 Open Academy x ERDERA Schools offer patient advocates and early-career researchers the opportunity to strengthen their knowledge and participation in rare disease research.
How National Mirror Groups strengthen rare disease research and policy alignment in Europe

How National Mirror Groups strengthen rare disease research and policy alignment in Europe

By connecting national priorities with European initiatives, NMGs support stronger coordination, knowledge exchange and alignment across the rare disease ecosystem.
Conference "Advancement of Treatments for Rare Diseases" in Cyprus, June 2026

Cyprus conference connects European research priorities with the path to rare disease treatments

At the “Advancement of Treatments for Rare Diseases” conference in Nicosia, European and national policymakers joined clinicians, researchers, regulators, industry representatives and patient advocates to examine how stronger coordination can translate scientific progress into better prevention, diagnosis, treatment and access to care for people living with rare diseases.
State of the art rare disease country reports ERDERA 2025

State of the art 2025 rare disease country report: Sweden

This 2025 country report outlines the policy, research, care and support landscape for rare diseases in Sweden.

ERDERA's

search form